INVO Fertility Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
1analyst covering
FY Revenue (est.)
$10.4Mnext fiscal year
FY EPS (est.)
-$23.20next fiscal year
Monitoring Framework
Key Performance Indicators
Consolidated Clinic Revenue Annually6.7M
Total Revenue from All Clinics (Consolidated and Equity Method) Annually8M
Adjusted EBITDA Annually-3.2M
Watch Items
- Nasdaq Listing ComplianceTrigger: Delinquency notices regarding late periodic filings (Form 10-K and Form 10-Q)Action: File required periodic reports and restated financial statements to regain compliance with Nasdaq Listing Rule 5250(c)(1)
- Going Concern UncertaintyTrigger: Accumulated deficit of $91.4 million and insufficient cash to fund operations for the next 12 monthsAction: Secure additional external capital, execute on clinic-operations model, and manage outstanding debt obligations
- Pritts Litigation Settlement PaymentsTrigger: Outstanding settlement schedule of $6.0 million through December 31, 2026Action: Ensure sufficient liquidity to meet scheduled payment obligations to avoid default
Research as of 20 Jun 2026